Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences

Power Life Sciences Inc.500 enrolled

Overview

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Ulcerative Colitis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Ulcerative Colitis patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Ulcerative Colitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient is at least 18 years of age * Diagnosis of Ulcerative Colitis * Ability to understand the study procedures, benefits and risks, and sign a written informed consent document. Exclusion Criteria: * Inability to perform regular electronic reporting * Women who are pregnant, intend to become pregnant, or are lactating * Inability to perform regular electronic reporting

Outcomes

Primary Outcomes

Rate of patients who decide to join in an Ulcerative Colitis clinical trial

Time frame: 3 months

Number of Ulcerative Colitis patients who remain in clinical trial until completion